4Muzzarelli RA, Muzzarelli C, Tarsi R, et al. Fungistatic activity of modified chitosans against Saprolegnia parasitica. Biomacromolecules , 2001, 2(1): 165-169.
5Tarsi R, Corbin B, Pruzzo C, et al. Ettect of low molecular weight chitosans on the adhesive properties of oral streptococci. Oral Microbiol Immunol , 1998, 13(4):217-224.
6Chen XG, Wang Z, Liu WS, et al. The effect of carboxymethyl chitosan on proliferation and collagen secretion of normal and keloid skin fibroblats. Biomaterials, 2002,23(23):4609-4614.
7Zhou J, Elson C, Lee TD. Reduction in postoperative adhesion formation and re-formation after and abdominal operation with the use of N, O-carboxymethyl chitosan.Surgery, 2004, 135(3):307-312.
8Dicolo G, zambito Y, Bargalassi S, et al. Ettect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm ,2004, 273(1-2): 37-44.
9Lubben I M, Verhoef JC, Borchard G, et al. Chitosan and its derivatives in mucosal drug and vaccine delivery.Eur J Pharm. Sci, 2001, 14(3): 201-207.
10Thanou M, Nihot MT, Jansen M, et al. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. J Pharm Sci , 2001, 90(1): 38-46.
